intravascular brachytherapy

intravascular brachytherapy

Interventional cardiology The intracoronary administration of beta radiation to prevent restenosis of coronary arteries–which occurs in ±50% of Pts after balloon and other forms of angioplasty
References in periodicals archive ?
A large, multicenter, randomized study involving 384 patients, the Sirolimus-eluting CYPHER(R) Stent Versus Intravascular Brachytherapy In the Treatment of Patients with In-Stent Restenotic Coronary Artery Lesions, or SISR trial, showed that the CYPHER(R) Stent had a lower incidence of target vessel failure (TVF), the primary endpoint of the study, compared to intravascular brachytherapy in complex patients.
In my 25 years of battling heart disease, I have undergone three open heart surgeries, intravascular brachytherapy and multiple bare metal stent procedures," said Rehak.
Calibration and characterization of [beta]-particle sources for intravascular brachytherapy.
The first intravascular brachytherapy (radiation) system for recurrent blockages in coronary arteries previously treated with coronary artery stents is a vast improvement over existing technology, according to Paul Teirstein, director of interventional cardiology, Scripps Clinic, La Jolla, Calif.
This year we also completed a safety and feasibility trial of our TheraSource(R) Intravascular Brachytherapy System for the prevention of restenosis, or renarrowing, of leg arteries following treatment of peripheral vascular disease by balloon angioplasty.
Randomized Study of Sirolimus-Eluting Stent Implantation Versus Coronary Brachytherapy for Diffuse In-Stent Restenosis -- This randomized study of 129 patients from Korea compares the safety and efficacy of the CYPHER(R) Stent and intravascular brachytherapy in the treatment of in-stent restenosis.
A Scripps Institute randomized trial of intravascular brachytherapy with IVUS guidance of symmetrical radiation to prevent in-stent restenosis demonstrated a 68.
Our current internal diversification focus is on our TheraP trial, our patented peripheral intravascular brachytherapy device, which has now been implanted in 14 patients.
Commenting on the results of the TROPICAL Study comparing the CYPHER Stent to intravascular brachytherapy (low dose radiation), for the treatment of in- stent restenosis (reblockage), principal investigator Professor Franz-Josef Neumann, Medical Clinic, University of Munich, Germany said: "In the treatment of in-stent restenosis, the CYPHER Sirolimus-eluting Stents provided an average in-lesion late loss of <0.
The study will test the safety and feasibility of the Company's TheraSource(TM) Intravascular Brachytherapy System designed to prevent restenosis, or renarrowing, of leg arteries following treatment of peripheral vascular disease by percutaneous transluminal angioplasty (PTA), also known as balloon angioplasty.
Additional exciting news for Theragenics(TM) is the commencement of human clinical trials to test the feasibility of the TheraSource(TM) Intravascular Brachytherapy System.
This exciting technology is an outstanding complement to our existing radiation oncology services; including 3D Conformal Therapy, intravascular brachytherapy, and permanent prostate seed implantation, that provide our patients more options than ever before," said Dr.

Full browser ?